Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Vaccine Effectiveness × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Prostatic Neoplasms 10 Stomach Neoplasms 7 Neoplasms 7 Lung Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Multiple Myeloma 6 Waldenstrom Macroglobulinemia 5 Uterine Cervical Neoplasms 4 Melanoma 4 Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Tuberous Sclerosis 3 Tobacco Use Disorder 3 Sarcoma 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioma 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Tobacco Use Cessation 2 Tobacco Smoking 2 Thoracic Neoplasms 2 Thoracic Diseases 2 Stomatitis 2 Smoking Cessation 2 Skin Neoplasms 2 Rectal Neoplasms 2

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡